About 46,XY difference of sex development due to isolated 17,20-lyase deficiency
46,XY difference of sex development due to isolated 17,20-lyase deficiency is a rare disease catalogued by Orphanet (ORPHA:90796). It is associated with the CYB5A, CYP17A1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to 46,XY difference of sex development due to isolated 17,20-lyase deficiency trials.
Search ClinicalTrials.gov for "46,XY difference of sex development due to isolated 17,20-lyase deficiency" or filter by Orphanet code ORPHA:90796 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting 46,XY difference of sex development due to isolated 17,20-lyase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for 46,XY difference of sex development due to isolated 17,20-lyase deficiency. Updated daily.